Dr Mark Douglas shares his experience of treating a patient with boceprevir and provides a brief update on the new hepatitis C therapies in development.
Target audience: General Practitioners, nurses and other managing clients on hepatitis C treatment.
CPD: Community HCV s100 Prescribers will receive 1 HCV CPD point for watching this webinar.
Type: Webinar (2014)
Funded by: NSW Health